The Journal of the Korea Contents Association (한국콘텐츠학회논문지)

The Korea Contents Association (한국콘텐츠학회)
권호 표지
DOI QR코드

DOI QR Code

Seaweed Derived Oligosaccharides and its Health Beneficial Effects on Gut Health

해조류 유래 다당류와 장 건강

  • 양효선 (제주대학교 식품영양학과) ;
  • 이윤경 (제주대학교 식품영양학과)
  • Received : 2016.05.16
  • Accepted : 2016.06.17
  • Published : 2016.07.28
Download PDF
⟨ Previous Next ⟩

Abstract

The incidence of inflammatory bowel disease(IBD) has increased continuously in worldwide, but no cure have been discovered. The etiology of IBD may include various factors such as genetics, epigenetic, environment as well as host immune system. Among the environmental factors of IBD, diet heavily influences gut health, especially non-digestible dietary fiber can have a great impact on selective growth of beneficial gut microbiota called probiotics. Seaweeds have been consumed in Asia countries and are a rich source for dietary fiber. Accumulated data have suggested the possibility of utilizing seaweed derived oligosaccharides as prebiotics to prevent IBD and its recurrence. In this review, seaweed derived oligosaccharides such as fucoidan and laminarin regarding gut health and potential therapeutic tools for IBD will be discussed based on studies conducted in vitro and in vivo models.

전 세계적으로 염증성 장질환의 발병률이 지속적인 증가추세를 보이는 가운데, 그 원인과 기전에 대한 적극적인 연구가 진행되고 있음에도 불구하고 아직 뚜렷한 치료제의 개발은 미비한 실정이다. 염증성 장질환의 원인에는 유전적, 후생유전적, 환경적 요인 외에도 숙주의 면역상태 등이 복합적으로 영향을 미치는 것으로 보고되어 있으며 특히 환경적인 요인 중 식이는 장 건강에 큰 영향을 미친다. 인간의 소화 작용에 의해 분해되지 않고 장까지 도달하는 난소화성 식이 섬유소는 장내 미생물의 먹이로 사용되고 선택적으로 바람직한 장내 미생물인 프로바이오틱스(probiotics)의 성장에 영향을 주는 프리바이오틱스(prebiotics)의 기능을 수행함으로써 장 건강에 긍정적인 영향을 준다고 알려져 있다. 최근 풍부한 식이 섬유소롤 함유하고 있는 해조류 유래 다당류의 프리바이오틱스로의 기능이 대두되면서 장 건강 증진을 위한 기능성 물질로써의 역할과 그 기전 연구가 활발히 진행되고 있다. 본 총설에서는 해조류 유래 다당류, 주로 후코이단과 라미나린 등이 장 건강과 장내 미생물의 성장에 미치는 영향 및 염증성 장질환의 재발과 치료를 위한 잠재적인 기능성 원료로써 가능성을 in vitro와 in vivo 실험 결과를 바탕으로 논의해 보도록 하겠다.

Keywords

References

  1. P. Bourlioux, B. Koletzko, and F. Guarner, "The Intestine and its Microflora are Partners for the Protection of the Host," Am J. of Clinical Nutrition, Vol.78, No.4, pp.675-683, 2003. https://doi.org/10.1093/ajcn/78.4.675
  2. D. Hollander, "Intestinal Permeability, Leaky Gut, and Intestinal Disorders," Current Gastroenterology Reports, Vol.1, No.5, pp.410-416, 1999. https://doi.org/10.1007/s11894-999-0023-5
  3. M. Silverman and M. Ostro, "Bacterial Endotoxin in Human Disease," Princeton, NJ: KPMG, Vol.35, 1999.
  4. E. Y. Choi, K. K. Cho, and I. S. Choi, "Inflammatory Bowel Disease and Cytokine," J Life Sciences, Vol.23, No.3, pp.448-461, 2013.
  5. 장병익, "염증성 장질환의 최신지견," 영남의대학술지, 제24권, 제2호, pp.S221-S233, 2007.
  6. R. Rahimi, S. Nikfar, and M. Abdollahi, "Induction of Clinical Response and Remission of Inflammatory Bowel Disease by use of Herbal Medicines: A Meta-Analysis," World J gastroenterol, Vol.19, No.34, pp.5738-5749, 2003. https://doi.org/10.3748/wjg.v19.i34.5738
  7. L. J. Dixon, A. Kabi, and K. P. Nickerson, "Combinatorial effects of diet and genetics inflammatory bowel disease pathogenesis," Inflammatory bowel diseases, Vol.21, pp.912-922, 2015. https://doi.org/10.1097/MIB.0000000000000289
  8. G. D. Wu, J. Chen, and C. Hoffmann, "Linking Long-Term Dietary Patterns with Gut Microbial Enterotypes," Science, Vol.334, No.6052, pp.105-108, 2011. https://doi.org/10.1126/science.1208344
  9. D. E. Serban, "Microbiota in inflammatory bowel disease pathogenesis and therapy: Is it all about diet?," Nutrition in Clinical Practice, Vol.30, pp.760-779, 2015. https://doi.org/10.1177/0884533615606898
  10. P. Louis, G. L. Hold, and H. J. Flint, "The Gut Microbiota, Bacterial Metabolites and Colorectal Cancer," Nature reviews Microbiology, Vol.12, pp.661-672, 2014 https://doi.org/10.1038/nrmicro3344
  11. G. R. Glenn and M. B. Roberfroid, "Dietary modulation of the human colonic microbiota," J of nutrition, Vol.125, No.6, pp.1401-1412, 1995.
  12. P. R. Marteau, M. de Vrese, and C. J. Cellier, "Protection from Gastrointestinal Diseases with the use of Probiotics," The American J of Clinical Nutrition, Vol.73, No.2, pp.430S-436S, 2001. https://doi.org/10.1093/ajcn/73.2.430s
  13. 이신지, 이명종, 정지은, "장내 상피세포 점막 투과성에 대한 유산균 및 금은화의 효과," 한국식품영양과학회지, 제41권, 제7호, pp.881-887, 2012. https://doi.org/10.3746/JKFN.2012.41.7.881
  14. S. U. Kadam, B. K. Tiwari, and C. P. O'Donnell, "Extraction, Structure and Biofunctional Activities of Laminarin from Brown Algae," International J of Food Science and Technology, Vol.50, No.1, pp.24-31, 2015 https://doi.org/10.1111/ijfs.12692
  15. J. Kang, M. Khan, and N. Park, "Antipyretic, Analgesic, and Anti-Inflammatory Activities of the Seaweed Sargassum Fulvellum and Sargassum Thunbergii in Mice," J of Ethnopharmacology, Vol.116, No.1, pp.187-190, 2008. https://doi.org/10.1016/j.jep.2007.10.032
  16. Y. V. Yuan and N. A. Walsh, "Antioxidant and Antiproliferative Activities of Extracts from a Variety of Edible Seaweeds," Food and Chemical Toxicology, Vol.44, No.7, pp.1144-1150, 2006. https://doi.org/10.1016/j.fct.2006.02.002
  17. A. Val, G. Platas, and A. Basilio, "Screening of Antimicrobial Activities in Red, Green and Brown Macroalgae from Gran Canaria," International Microbiology, Vol.4, No.1, pp.35-40, 2001. https://doi.org/10.1007/s101230100006
  18. W. A. Pushpamali, C. Nikapitiya, and M. De Zoysa, "Isolation and Purification of an Anticoagulant from Fermented Red Seaweed Lomentaria Catenata," Carbohydrate Polymers, Vol.73, No.2, pp.274-279, 2008. https://doi.org/10.1016/j.carbpol.2007.11.029
  19. L. O'Sullivan, B. Murphy, and P. McLoughlin, "Prebiotics from Marine Macroalgae for Human and Animal Health Applications," Marine drugs, Vol.8, No.7, pp.2038-2064, 2010. https://doi.org/10.3390/md8072038
  20. E. V. Loftus, "Clinical Epidemiology of Inflammatory Bowel Disease: Incidence, Prevalence, and Environmental Influences," Gastroenterology, Vol.126, No.6, pp.1504-1517, 2004. https://doi.org/10.1053/j.gastro.2004.01.063
  21. D. H. Shin, D. H. Sinn, and Y. Kim, "Increasing Incidence of Inflammatory Bowel Disease among Young Men in Korea between 2003 and 2008," Digestive Diseases and Science, Vol.56, No.4, pp.1154-1159, 2011. https://doi.org/10.1007/s10620-010-1403-2
  22. W. Strober, I. Fuss, and P. Mannon, "The Fundamental Basis of Inflammatory Bowel Disease," J of Clinical Investigation, Vol.117, No.3, pp.514-521, 2007. https://doi.org/10.1172/JCI30587
  23. S. Wirtz and M. F. Neurath, "Mouse models of inflammatory bowel disease," Advanced Drug Delivery Reviews, Vol.59, No.11, pp.1073-1083, 2007. https://doi.org/10.1016/j.addr.2007.07.003
  24. J. O. Clarke and G. E. Mullin, "A Review of Complementary and Alternative Approaches to Immunomodulation," Nutrition in Clinical Practice, Vol.23, No.1, pp.49-62, 2008. https://doi.org/10.1177/011542650802300149
  25. A. Iraha, H. Chinen, and A. Hokama, "Fucoidan Enhances Intestinal Barrier Function by Upregulating the Expression of Claudin-1," World J of Gastroenterology, Vol.19, No.33, pp.5500-5507, 2013. https://doi.org/10.3748/wjg.v19.i33.5500
  26. G. Rogler, "Gastrointestinal and Liver Adverse Effects of Drugs used for Treating IBD," Best Practice & Research Clinical Gastroenterology, Vol.24, No.2, pp.157-165, 2010. https://doi.org/10.1016/j.bpg.2009.10.011
  27. S. Matsumoto, M. Nagaoka, and T. Hara, "Fucoidan Derived from Cladosiphon Okamuranus Tokida Ameliorates Murine Chronic Colitis through the Down Regulation of IL-6 Production on Colonic Epithelial Cells," Clinical and Experimental Immunology, Vol.136, No.3, pp.432-439, 2004. https://doi.org/10.1111/j.1365-2249.2004.02462.x
  28. C. Deville, M. Gharbi, and G. Dandrifosse, "Study on the Effects of Laminarin, a Polysaccharide from Seaweed, on Gut Characteristics," J of the Science of Food and Agriculture, Vol.87, No.9, pp.1717-1725, 2007. https://doi.org/10.1002/jsfa.2901
  29. P. Reilly, J. O'doherty, and K. Pierce, "The Effects of Seaweed Extract Inclusion on Gut Morphology, Selected Intestinal Microbiota, Nutrient Digestibility, VFA Concentrations and the Immune Status of the Weaned Pig," Animal, Vol.2, No.10, pp.1465-1473, 2008. https://doi.org/10.1017/S1751731108002711
  30. T. Tanoue, Y. Nishitani, and K. Kanazawa, "In Vitro Model to Estimate Gut Inflammation using Co-Cultured Caco-2 and RAW264. 7 Cells," Biochemical and Biophysical ResearchCommunications, Vol.374, No.3, pp.565-569, 2008. https://doi.org/10.1016/j.bbrc.2008.07.063
  31. A. G. Smith, J. O'Doherty, and P. Reilly, "The Effects of Laminarin Derived from Laminaria Digitata on Measurements of Gut Health," British J of Nutrition, Vol.105, No.5, pp.669-677, 2011. https://doi.org/10.1017/S0007114510004277
  32. S. J. Ko, Y. Bu, and J. Bae, "Protective Effect of Laminaria Japonica with Probiotics on Murine Colitis," Mediators of Inflammation, Vol.2014, pp.1-10, 2014.
  33. M. Lahaye, "Marine Algae as Sources of Fibres: Determination of Soluble and Insoluble Dietary Fibre Contents in some 'sea Vegetables'," Journal of Science of Food and Agriculture, Vol.54, No.4, pp.587-594, 1991. https://doi.org/10.1002/jsfa.2740540410
  34. M. Miyata, T. Koyama, and T. Kamitani, "Anti-Obesity Effect on Rodents of the Traditional Japanese Food, Tororokombu, Shaved Laminaria," Bioscience, Biotechnology, and Biochemistry, Vol.73, No.10, pp.2326-2328, 2009. https://doi.org/10.1271/bbb.90344
  35. A. Jimenez-Escrig and F. Sanchez-Muniz, "Dietary Fibre from Edible Seaweeds: Chemical Structure, Physicochemical Properties and Effects on Cholesterol Metabolism," Nutritional Research, Vol.20, No.4, pp.585-598, 2000. https://doi.org/10.1016/S0271-5317(00)00149-4
  36. E. Gomez-Ordonez, A. Jimenez-Escrig, and P. Ruperez, "Dietary Fibre and Physicochemical Properties of several Edible Seaweeds from the Northwestern Spanish Coast," Food Research International, Vol.43, No.9, pp.2289-2294, 2010. https://doi.org/10.1016/j.foodres.2010.08.005
  37. 이명숙, 이윤경, "해조류의 섭취가 비만과 식이섭취에 미치는 영향," 한국콘텐츠학회논문지, 제14권, 제12호, pp.478-485, 2014.
  38. J. Y. Oh, Bioactivity of secondary metabolites and growth activity of lactic acid bacteria (LAB) under modified seaweed culture medium, MS Thesis, Jeju National University, 2014.
  39. T. Debnath, D. H. Kim, and B. O. Lim, "Natural products as a source of anti-inflammatory agents associated with inflammatory bowel disease," Molecules, Vol.18, No.6, pp.7253-7270, 2013. https://doi.org/10.3390/molecules18067253
  40. J. H. Cummings, "Short chain fatty acids in the human colon," Gut, Vol.22, No.9, pp.763-779, 1981. https://doi.org/10.1136/gut.22.9.763
  41. D. R. Donohoe, G. Nikhil, and X. Zhang, "The Microbiome and Butyrate Regulate Energy Metabolism and Autophagy in the Mammalian Colon," Cell Metabolism, Vol.13, No.5, pp.517-526, 2011. https://doi.org/10.1016/j.cmet.2011.02.018